Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Quintas-Cardama
Outcome of Patients With Chronic Myeloid Leukemia With Multiple ABL1 Kinase Domain Mutations Receiving Tyrosine Kinase Inhibitor Therapy
Haematologica
Hematology
Related publications
Planned Pregnancy in Female Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
Oncologist
Cancer Research
Medicine
Oncology
Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia
Oncology and Therapy
Oncology
Managing Chronic Myeloid Leukemia Patients Intolerant to Tyrosine Kinase Inhibitor Therapy
Blood Cancer Journal
Oncology
Hematology
The Impact of BCR-ABL1 Transcript Type on Tyrosine Kinase Inhibitor Responses and Outcomes in Patients With Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
Arterial Events in Patients With Chronic Myeloid Leukemia Receiving Treatment With Second Generation Tyrosine Kinase Inhibitors
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia
Molecular Therapy - Nucleic Acids
Drug Discovery
Molecular Medicine
The Relation of Common ABL Kinase Domain Mutations With Resistance to Tyrosine Kinase Inhibiters in Patients With Chronic Myeloid Leukemia in Middle Euphrates of Iraq
International Journal of Scientific Research and Management
Effect of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia (Cytogenetic, Molecular Response) in Mosul
Annals of the College of Medicine, Mosul
Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
